Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

4,4',6-trimethylangelicin

Known as: 4,4',6-TMA, 4,6,4'-trimethylangelicin, 2H-Furo(2,3-h)-1-benzopyran-2-one, 4,6,9-trimethyl-, (5Z,11alpha,13E,15S)- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Cystic fibrosis transmembrane conductance regulator (CFTR) carrying the F508del mutation is retained in endoplasmic reticulum and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
Chronic inflammatory response in the airway tract of patients affected by cystic fibrosis is characterized by an excessive… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
2002
2002
Although 8-methoxypsoralen (8-MOP) has been successfully used in extracorporeal photochemotherapy (ECP) of several T cell… Expand
1996
1996
With the aim of obtaining new potential photochemotherapeutic agents, having increased antiproliferative activity and decreased… Expand
1995
1995
The frequencies of micronuclei induced by treatment with 4,4',6-trimethylangelicin (TMA) and 8-methoxypsoralen (8-MOP) have been… Expand
1994
1994
The furocourmarins 3-carbethoxypsoralen (3-CP) and 4,4',6-trimethylangelicin (TMA) were generally believed to be incapable of… Expand
1993
1993
The capacity of some linear and angular furocoumarins to induce DNA‐protein cross‐links by UVA (320–400 nm) irradiation has been… Expand
1991
1991
Photoinduced binding of drugs to endogenous biomacromolecules may cause both toxic and therapeutic effects. For example… Expand
1991
1991
Summary The incidence and clinical features of allergic contact and/or photocontact dermatitis due to psoralens were examined in… Expand
1984
1984
Abstract— 4,4',6‐Trimethylangelicin is a new monofunctional furocoumarin which appears to be a very promising potential agent for… Expand